Employee Login
ICMR - National AIDS Research Institute
Logo Thing main logo
Logo Thing main logo

Profile

DR ABHIJIT V. KADAM
Name : DR ABHIJIT V. KADAM
Designation : Scientist D
Division : Clinical Sciences
Email ID : [email protected]
Area Of Interest : Pharmacovigilance, Herbal drugs, Drug utilization research and Pharmacokinetics and dynamics of antiretroviral drugs and Antimicrobial resistance
Completed and Ongoing Projects
Awards and Honours
  • ASICON 2015 Scholarship was awarded.
  • OAR-IAS 2017 Scholarship was awarded
  • Received Award and Certificate inrecognition for my exemplary services during Nipah Outbreaks in Kerala through Dr. Prof. Padmashree Balram Bhargava, Secretary, Department of Health Research, MoH&FW, Goverment of India; Director-General, ICMR, New Delhi on 05 November 2019.
Work Experience

 Research Experience:

Duration (From-To)

Institution

Particulars of work done

31/05/2007- 31/5/2010

Netaji Subhash Chandra Bose

Medical College and Research

Jabalpur , M.P. 

Demonstrator /Tutor

28/06/2010- 17/09/2012

Azeezia Institute of Medical       Sciences  and Research                     Kollam , Kerala              

Assistant Professor

21/09/2012-05/06/2013

Institute of MedicalSciences  and Research, Mayani, Satara, Maharashtra

Assistant Professor

11/06/2013 -31/08/2017

ICMR-National AIDS Research Institute, Pune

Scientist B

01/09/2017 till date

ICMR-National AIDS Research Institute, Pune

Scientist C

 Other Experiences:

Duration (From-To)

Institution     

Particulars of work done

2010-2012        

Azeezia Institute of Medical       Sciences  and Research                     Kollam , Kerala                        

 

Skilled Assistant & Associate    Examiner for University Exam

Member Secretary, Ethics committee & Pharmacovigilance and therapeutic committee.

2015-2018

M.Sc. Virology Course Co-ordinator

HIV part of M.Sc. Virology course Co-ordinator

2017-2018

DBT Star College, Programme

Three lectures taken at various colleges

List of Grant Recieved

List of grants received

Sr.No.

Title of Project

Duration

Funding Agency

Role

1

“Multicenter, non-randomized, non-controlled, open-label Phase IV trial to evaluate the safety, tolerability and Effectiveness of Dolutegravir 50 mg tablet  along with other antiretrovirals  among HIV-1 Infected subjects.”

Three years

Extramural

PI

2

“Estimating Incremental Cost of treating Antimicrobial Resistant infections in India”

Two years

Extramural

ICMR

Co-PI

3

A phase IIB Open Label Randomized Controlled Clinical trial to evaluate the Anti-bacterial activity, Pharmacokinetics, Safety and Tolerability of Metformin when given along with rifampicin, isoniazid, pyrazinamide and ethambutol in adults with newly diagnosed sputum positive Pulmonary Tuberculosis: an 8-week study (METRIF STUDY)

Three years

Extramural

PI  for duration from Oct 2019 to May 2019.

4

To   validate  method for tenofovir estimation in plasma  samples  of  FSW s  who are on PreP ( Tenofovirdisoproxilfumarate 300 mg and Emtricitabine 200 mg) under   a  demonstration project.

One year

Intramural +

 Extramural

Study

(Durbar

 Mahilla and Ashodaya

Samittii)

 

PI

5

Use of Herbal drugs and dietary supplements by HIV infected people and its effect on anti retroviral therapy

2 years

Intramural

PI

 

Conference/Training/Workshop Attended

Conferences/Trainings/Workshops Attended

Course/Title

Deputed/voluntary

From

To

Institution

Skill development programmee on Pharmacovigilance

Voluntary

01st March 2017

10th March

2017

NCC-PvPI, Indian

Pharmacopoiea

 Commission

ICH-GCP, Schedule 'Y', and NABH Accreditation

 

Deputed

23rd August 2017

-

Ethical Research

 Initiative, Pune.

How to write and submit a conference abstract

Voluntary

24 July 2017

 

International AIDS

Society conference,

 2017, Paris

Publish or Perish:

How to write a research manuscript ?

Voluntary

25July 2017

 

International AIDS

Society conference,

 2017, Paris

Trained in Hair Steroid analysis   by LCMS and Chemiluminescence method 

Deputed

12Dec 2016

16Dec

2016

Prof. Clemens

Kirschbaum

Technische

Universität  (TU )

Dresden Germany

under technology

transfer clause  of  the

 KGFS Study-‘Impact

of Microfinance on

Health: Evidence from

 India’. The training

 was fully supported

by IFMR Lead

Regulatory Environment for conducting Clinical Research in India – Empowering Sites & Ethics Committees

 

Deputed

28th April 2016

---

South Asian Chapter

of American College

 of Clinical

Pharmacology

 

 

Online course on research

Voluntary

18th Jan2016

20th March16

National Institute of

Epidemiology

Causality Assessment of SAEs: ISCR-MRCT Tool

Deputed

07Jan16

--

Indian society for

clinical research

Indo US joint collaboration workshop

Selected

10Dec15

11Dec15

Indo US joint

collaboration

Selected for  Pre meeting workshop entitled “WHO ATC/DDD methodology and drug utilization research” in Delhi on  2nd-3rdNov. 2015 

 

Selected

02Nov15

03Nov15

WHO and PVPI

 

Thirty-eighth Annual Meeting of Representatives of National Centres participating in the WHO Programme for International Drug Monitoring

Invitation

4th November 2015

 

WHO and PVPI

 Participation   in

 working group

 

“Current Regulatory Requirements for members of Institutional Ethical Committee”.

Deputed

11Feb15

12 Feb15

Awareness

programme held

on at NCCS , Pune,

 organized by CDSA

Online course by Coursera : “Data Management for Clinical Research"

Voluntary

2Jun14

28July 14

Vanderbilt University

and received a Statement of Accomplishment

on 30th  July14

 

Online ICH – GCP

training

Deputed

13June13

--

CITI Collabrative

Programme.

Number of Publications : 7
List of Publications

 Recent publications (last 5years, with titlesand references), also papers in press Kadam AV,Ghate MV, Chinchkar V, Gurav SG, Gangakhedkar RR. Use of herbal drugs and its effect on CD4 count in HIV infected individuals taking antiretroviral therapy in Pune. Int J of Medi Sci 2018;5(8):4-8.

 

2.Kadam AV, Bembalkar SC, Panchal NU, Mamulwar MS, Shete AV, Godbole SV. Persons living with HIV continue to present late for care: A trend analysis from 2011 to 2015. Indian J Sex Transm Dis 2019; 40:133-8

 

  1. Sahay RR, Yadav PD, Gupta N, Shete AM, Radhakrishnan C, Mohan G, Menon N, Bhatnagar T, Suma K, Kadam AV, Ullas PT, Anu Kumar B, Sugunan AP, Sreekala VK, Khobragade R, Gangakhedkar RR, Mourya DT. Experiential learnings from the Nipah virus outbreaks in Kerala towards containment of infectious public health emergencies in India. Epidemiol Infect. 2020 Apr 23; 148:e90. doi: 10.1017/S0950268820000825.

 

  1. Jana S, Ray P, Roy S, Kadam A, Gangakhedkar RR, Rewari BB, Moses S, Becker ML. Successful integration of HIV pre-exposure prophylaxis into a community-based HIV prevention program for female sex workers in Kolkata, India. Int J STD AIDS. 2021 Jun;32(7):638-647. doi: 10.1177/0956462420983992. Epub 2021 Feb 18.

 

 

Papers published as a study team member: Two Papers in New England Journal of Medicine

 

  1. WHO Solidarity Trial Consortium, Pan H, Peto R, et al Repurposed antiviral drugs for Covid-19 - Interim WHO Solidarity Trial results. N Engl J Med. 2021 Feb 11; 384(6):497-511. doi: 10.1056/NEJMoa2023184. Epub 2020 Dec 2.

 

  1. Cohen MS, Chen YQ, McCauley M, et al Antiretroviral therapy for the prevention of HIV-1 transmission. N Engl J Med. 2016 Sep 1; 375(9):830-9. doi: 10.1056/NEJMoa1600693. Epub 2016 Jul 18.

Review Papers: One paper in peer-reviewed journal

 

  1. Vaidya KA, Kadam AV and Nema V. Anti-Retroviral Drugs for HIV: Old and New. Austin J HIV/AIDS Res. 2016; 3(2): 1026.

 

Number of Papers presented in conference/Proceedings: Four

  1. Kadam AV, Bagul R ,Gurav N, Chinchkar V, Ghate MV, Gangakhedkar RR: Use of Herbal drugs by PLHA on ART: Data from cross sectional study done at NARI, Pune. Presented at International AIDS Society conference at Paris in July 2017

 

  1. S. Godbole,A.V.Kadam, S. Deshpande, A. Lokhande, S. Karkal, R. Gangakhedkar. Improving access to HIV testing among hard to reach and hidden sex workers in India: will uptake of HIV test increase if testing services are provided at the door-step?

Presented at International AIDS Society conference at Paris in July 2017  

 

  1. Kadam AV, Bagul RR, GuravN, Chinchkar V, Ghate MV, Gangakhedkar RR: Use of Herbal drugs by PLHA who were ART naive: Data from cross sectional study done at NARI, Pune. 

Poster presented at ASICON meeting 2015, Mumbai

 

  1. Kadam AV, Pandey SP et al (2009), Effects of Amisulpiride 200mg and Olanzapine 10 mg on Fasting Blood Sugar, Sr. Triglycerides and BMI .Poster Presented at International conference on Integrated and Personalized medicine and 42nd Annual conference of Indian Pharmacological Society 2009